Cheese delivers 67 grams of protein per ounce, helping preserve lean muscle mass and supporting metabolic function
For most patients, the following considerations help to guide the choice between the two medications: Mounjaro may be the more appropriate choice if: Maximising weight loss is your primary clinical goal and you are comfortable with a weekly injection You have type 2 diabetes alongside obesity tirzepatide has a particularly well-established evidence base in this population and the dual mechanism may offer additional metabolic benefits You have tried Wegovy without adequate results and are looking for a more potent alternative Your BMI is at the higher end of the eligible range and you want the treatment with the greatest average efficacy Wegovy may be the more appropriate choice if: You have a strong preference for a medication with a longer UK clinical track record and broader real-world evidence base You prefer or require an oral option the Wegovy tablet is now MHRA-approved and offers the same active ingredient (semaglutide) without the need for injection, making it a genuinely valuable option for patients with needle phobia or a strong preference for oral medication Wegovy is more accessible or better suited to your circumstances following a clinical assessment You have previously responded well to semaglutide in another formulation and are familiar with its side effect profile The most reliable way to identify the right choice for your circumstances is through a clinical consultation that takes your full medical history, current medications, BMI, lifestyle, and personal preferences into account
1.05.26 MDL numbers grew in December More plaintiffs filed GLP-1 RA lawsuits in December, bringing the total to 3,063
Best Candidates for Topical GHK-Cu GHK-Cu is not a universal solution for GHK-Cu and loose skin
Before recommending B12 injections, providers may review a patients overall health, symptoms, and wellness goals to determine whether this option is suitable
